Live feed
Filing
SC 13G/A
SC 13G/A0000080255-24-001447·Akero Therapeutics, Inc.
Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Security class unavailable · CUSIP: 00973Y108
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,808,359
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-24-001447
- Form type
- SC 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership